Annual report
3154.TEDINET S100Z02J
Period2024-07-01 → 2025-06-30
Filed2026-09-03
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100WQP5. Amended by S100Z0AX (2026-09-03).
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥288.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥259.8bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥239.1bn | 2022-07-01 → 2023-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥226.6bn | 2021-07-01 → 2022-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥213.3bn | 2020-07-01 → 2021-06-30v | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2024-07-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2023-07-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2022-07-01 → 2023-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2020-07-01 → 2021-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2024-07-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2023-07-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2022-07-01 → 2023-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.1bn | 2020-07-01 → 2021-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥113.0bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥114.8bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥97.5bn | at 2023-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥93.0bn | at 2022-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥84.5bn | at 2021-06-30v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥92.5bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥95.1bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.5bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2023-06-30v | Cons. | Net assets |
| Net assets / equity | ¥17.3bn | at 2022-06-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥15.8bn | at 2021-06-30v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.3bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.6bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.3bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2023-06-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2022-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥12.6bn | at 2021-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥3.9bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.8bn | 2020-07-01 → 2021-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥863m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.8bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.6bn | 2020-07-01 → 2021-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.0bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥863m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥5.2bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2020-07-01 → 2021-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥61.91 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.21 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.32 | 2022-07-01 → 2023-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.81 | 2020-07-01 → 2021-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥61.85 | 2024-07-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51 | 2023-07-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥68.09 | 2022-07-01 → 2023-06-30v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥94.15 | 2020-07-01 → 2021-06-30v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥920.89 | at 2025-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥891.21 | at 2024-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥847.1 | at 2023-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥789.43 | at 2022-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥727.12 | at 2021-06-30v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 18.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.1% | at 2023-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.8% | at 2021-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.8% | 2024-07-01 → 2025-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2023-07-01 → 2024-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2022-07-01 → 2023-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2021-07-01 → 2022-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.9% | 2020-07-01 → 2021-06-30v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,614 | at 2025-06-30 | Cons. | Number of employees |
| Employees | 2,517 | at 2024-06-30 | Cons. | Number of employees |
| Employees | 2,288 | at 2023-06-30v | Cons. | Number of employees |
| Employees | 2,182 | at 2022-06-30v | Cons. | Number of employees |
| Employees | 2,002 | at 2021-06-30v | Cons. | Number of employees |
| Revenue | ¥3.0bn | 2024-07-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥2.9bn | 2023-07-01 → 2024-06-30 | Standalone | Net sales |
| Revenue | ¥3.0bn | 2022-07-01 → 2023-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2021-07-01 → 2022-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2020-07-01 → 2021-06-30v | Standalone | Net sales (5-year summary) |
| Operating income | ¥265m | 2024-07-01 → 2025-06-30 | Standalone | Operating income |
| Operating income | ¥458m | 2023-07-01 → 2024-06-30 | Standalone | Operating income |
| Ordinary income | ¥482m | 2024-07-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥707m | 2023-07-01 → 2024-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥968m | 2022-07-01 → 2023-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥998m | 2021-07-01 → 2022-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥703m | 2020-07-01 → 2021-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥482m | 2024-07-01 → 2025-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥707m | 2023-07-01 → 2024-06-30 | Standalone | Income before income taxes |
| Net income | ¥475m | 2024-07-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | ¥649m | 2023-07-01 → 2024-06-30 | Standalone | Profit loss |
| Net income | ¥1.0bn | 2022-07-01 → 2023-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥932m | 2021-07-01 → 2022-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥663m | 2020-07-01 → 2021-06-30v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥26.1bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥26.0bn | at 2024-06-30 | Standalone | Assets |
| Total assets | ¥22.8bn | at 2023-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.9bn | at 2022-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥21.5bn | at 2021-06-30v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥16.3bn | at 2025-06-30 | Standalone | Liabilities |
| Total liabilities | ¥16.1bn | at 2024-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥9.9bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥9.9bn | at 2024-06-30 | Standalone | Net assets |
| Net assets / equity | ¥9.3bn | at 2023-06-30v | Standalone | Net assets |
| Net assets / equity | ¥8.6bn | at 2022-06-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥8.1bn | at 2021-06-30v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥180m | at 2025-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥192m | at 2024-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥21.36 | 2024-07-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.55 | 2023-07-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.27 | 2022-07-01 → 2023-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.56 | 2021-07-01 → 2022-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.43 | 2020-07-01 → 2021-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥21.33 | 2024-07-01 → 2025-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.43 | 2023-07-01 → 2024-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.12 | 2022-07-01 → 2023-06-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥42.48 | 2021-07-01 → 2022-06-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.22 | 2020-07-01 → 2021-06-30v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥20 | 2024-07-01 → 2025-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21 | 2023-07-01 → 2024-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2022-07-01 → 2023-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2021-07-01 → 2022-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21 | 2020-07-01 → 2021-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥444.98 | at 2025-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥448.09 | at 2024-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥425.81 | at 2023-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥394.52 | at 2022-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥372.32 | at 2021-06-30v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 37.8% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2023-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2022-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.8% | at 2021-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.8% | 2024-07-01 → 2025-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2023-07-01 → 2024-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2022-07-01 → 2023-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2021-07-01 → 2022-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2020-07-01 → 2021-06-30v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 22,238,217 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 22,147,494 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,925,104 | at 2023-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,925,104 | at 2022-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2021-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 93 | at 2025-06-30 | Standalone | Number of employees |
| Employees | 93 | at 2024-06-30 | Standalone | Number of employees |
| Employees | 90 | at 2023-06-30v | Standalone | Number of employees |
| Employees | 71 | at 2022-06-30v | Standalone | Number of employees |
| Employees | 74 | at 2021-06-30v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-07-01 → 2025-06-30 | ¥475m |
| Reconciling Itemsreconciling | depreciation | 2024-07-01 → 2025-06-30 | ¥728m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2025-06-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2025-06-30 | −¥22m |
| Reconciling Itemsreconciling | segment assets | at 2025-06-30 | ¥43.2bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2025-06-30 | −¥9.1bn |
| Medical Equipment Salesreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥1.9bn |
| Medical Equipment Salesreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥617m |
| Medical Equipment Salesreportable segment | employees | at 2025-06-30 | 1920 pure |
| Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥282.7bn |
| Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥282.7bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥22m |
| Medical Equipment Salesreportable segment | segment assets | at 2025-06-30 | ¥68.3bn |
| Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥10.4bn |
| Nursing Welfarereportable segment | capex | 2024-07-01 → 2025-06-30 | ¥433m |
| Nursing Welfarereportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥528m |
| Nursing Welfarereportable segment | employees | at 2025-06-30 | 202 pure |
| Nursing Welfarereportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥6.0bn |
| Nursing Welfarereportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥6.0bn |
| Nursing Welfarereportable segment | segment assets | at 2025-06-30 | ¥1.5bn |
| Nursing Welfarereportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥516m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-07-01 → 2025-06-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-07-01 → 2025-06-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2025-06-30 | ¥288.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2025-06-30 | ¥288.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-06-30 | ¥69.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2025-06-30 | ¥11.0bn |
| Reconciling Itemsreconciling | capex | 2023-07-01 → 2024-06-30 | ¥1.7bn |
| Reconciling Itemsreconciling | depreciation | 2023-07-01 → 2024-06-30 | ¥683m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2024-06-30 | −¥3m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2024-06-30 | −¥3m |
| Reconciling Itemsreconciling | segment assets | at 2024-06-30 | ¥48.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2024-06-30 | −¥8.3bn |
| Medical Equipment Salesreportable segment | capex | 2023-07-01 → 2024-06-30 | ¥1.3bn |
| Medical Equipment Salesreportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥346m |
| Medical Equipment Salesreportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥254.0bn |
| Medical Equipment Salesreportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥254.0bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥3m |
| Medical Equipment Salesreportable segment | segment assets | at 2024-06-30 | ¥64.6bn |
| Medical Equipment Salesreportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥9.2bn |
| Nursing Welfarereportable segment | capex | 2023-07-01 → 2024-06-30 | ¥444m |
| Nursing Welfarereportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥503m |
| Nursing Welfarereportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥5.8bn |
| Nursing Welfarereportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥5.8bn |
| Nursing Welfarereportable segment | segment assets | at 2024-06-30 | ¥1.5bn |
| Nursing Welfarereportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥436m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-07-01 → 2024-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-07-01 → 2024-06-30 | ¥849m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2024-06-30 | ¥259.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2024-06-30 | ¥259.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-06-30 | ¥66.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2024-06-30 | ¥9.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,714
| Item | Context | Value | Unit |
|---|---|---|---|
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsExcludingAuditAndSupervisoryCommitteeMember | 162267000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsExcludingAuditAndSupervisoryCommitteeMember | 93300000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsExcludingAuditAndSupervisoryCommitteeMember | 67718000 | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsExcludingAuditAndSupervisoryCommitteeMember | 1249000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsExcludingAuditAndSupervisoryCommitteeMember | 6 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMember | 31293000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMember | 31293000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000DirectorsAppointedAsAuditAndSupervisoryCommitteeMember | 2 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000OutsideDirectorAuditAndSupervisoryCommitteeMemberMember | 48600000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000OutsideDirectorAuditAndSupervisoryCommitteeMemberMember | 48600000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000OutsideDirectorAuditAndSupervisoryCommitteeMemberMember | － | JPY |
| Share awards remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000OutsideDirectorAuditAndSupervisoryCommitteeMemberMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_jpcrp030000-asr_E22995-000OutsideDirectorAuditAndSupervisoryCommitteeMemberMember | 7 | |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 3 | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 344780000 | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 6 | |
| Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 2360681000 | JPY |
| Number of issues whose number of shares increased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total acquisition cost for increased shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares increased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 1 | |
| Total acquisition cost for increased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 3340000 | JPY |
| Number of issues whose number of shares decreased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total sale amount for decreased shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares decreased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total sale amount for decreased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 750400 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 750400 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 1988560000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 1990811000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 155780 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 154335 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 267163000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 400269000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 50000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 50000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 83900000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 77200000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | 9600 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 2400 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | 13017000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 10572000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | 2610 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row5Member | 2610 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | 6624000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row5Member | 7010000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | 1000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row6Member | 1000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | 1416000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |